Rigel to Present at Jefferies 2012 Global Healthcare Conference in London – Sacramento Bee
Rigel to Present at Jefferies 2012 Global Healthcare Conference in LondonSacramento Bee… R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 clinical trials; and R…
